Lee Sung Insider Trades

Insider Trading History

Track insider trading activity for Lee Sung. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tango Therapeutics
Tango Therapeutics TNGX
Director
Holding Value $649k 22,870 shares
Last Trade
Jun 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.7k 4,140 shares
$20.22
$28.39
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.06M 63,221 shares
Last Trade
May 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.84M 23,906 shares
$76.87
$80.01
Tango Therapeutics
Tango Therapeutics TNGX
Director
Holding Value $633k 22,300 shares
Last Trade
Apr 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$386k 17,500 shares
$22.06
$28.39
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $6.97M 87,127 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$307k 4,935 shares
$62.15
$80.01
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $7.37M 92,062 shares
Last Trade
Mar 15, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.11M 51,791 shares
$60.06
$80.01
Tango Therapeutics
Tango Therapeutics TNGX
Director
Holding Value $1.7M 60,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$597k 70,000 shares
$8.53
$28.39
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.78M 72,221 shares
Last Trade
Dec 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$282k 4,304 shares
$65.60
$80.01
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.71M 71,416 shares
Last Trade
Dec 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$50.5k 805 shares
$62.72
$80.01
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.43M 67,917 shares
Last Trade
Dec 03, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$101k 1,560 shares
$65.02
$80.01
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.56M 69,477 shares
Last Trade
Jun 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$155k 4,965 shares
$31.21
$80.01
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $5.96M 74,442 shares
Last Trade
Mar 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.23M 50,342 shares
$44.36
$80.01
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $3M 37,451 shares
Last Trade
Dec 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$79.1k 1,536 shares
$51.51
$80.01
Cytokinetics
Cytokinetics CYTK
Evp, Chief Financial Officer
Holding Value $4.27M 53,417 shares
Last Trade
May 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.59M 53,417 shares
$48.51
$80.01
Vir Biotechnology
Vir Biotechnology VIR
EVP & Chief Financial Officer
Holding Value $1.02M 100,492 shares
Last Trade
Mar 27, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$59.4k 6,008 shares
$9.89
$10.16
Vir Biotechnology
Vir Biotechnology VIR
EVP & Chief Financial Officer
Holding Value $1.08M 106,500 shares
Last Trade
Feb 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$809k 80,000 shares
$10.11
$10.16
Vir Biotechnology
Vir Biotechnology VIR
Chief Financial Officer
Holding Value $1.35M 133,000 shares
Last Trade
Mar 27, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.59M 199,500 shares
$23.01
$10.16
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Evp, Chief Financial Officer
Holding Value $6.48k 88,708 shares
Last Trade
Nov 25, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$49.3k 5,042 shares
$9.77
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Evp, Chief Financial Officer
Holding Value $7.35k 100,500 shares
Last Trade
Feb 25, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.02M 150,500 shares
$6.80
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
Evp, Chief Financial Officer
Holding Value $19.2k 262,000 shares
Last Trade
Nov 25, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.16M 305,750 shares
$10.35
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up